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IgG Responses to BP Transgenic Skin
Olasz and colleagues produced transgenic 
(Tg) mice expressing human bullous pemphi-
goid antigen 2 (BPAG2) in the murine epider-
mal basement membrane (BM). Tg skin grafts 
on wild-type or MHC I–/– mice elicited IgG that 
bound human epidermal BM and BPAG2. IgG 
production in grafted mice was prompt, robust, 
and durable, and correlated with the involution 
and loss of Tg skin grafts. This model approxi-
mates alterations seen in patients with BP, par-
allels immune responses in some patients with 
epidermolysis bullosa following BPAG2 gene replacement, and can help identify 
interventions that may block production of IgG against proteins in epidermal BM. 
See page 2807
Filaggrin Can Be a Genetic Modifier
Liao and colleagues studied a Scottish 
family in which two brothers had X-
linked ichthyosis; the younger broth-
er had typical fine scaling, whereas 
the older brother was more severely 
affected. Both carried the steroid sul-
fatase gene missense mutation T165I, 
but the older brother also carried the 
gene-encoding filaggrin (FLG) muta-
tion R501X. These findings suggest 
that coinheritance of two mutations 
may increase ichthyosis severity. 
Because the frequency of FLG mutations in people of European origin can be as 
high as 9%, filaggrin might be a genetic modifying factor in other genodermatoses. 
See page 2795
Confocal Microscopy and Melanoma
To study the sensitivity and specificity of 37 
confocal features for diagnosing melanoma, 
Pellacani and colleagues evaluated 136 melano-
mas and 215 nevi. Two blinded expert observers 
characterized melanomas primarily by epider-
mal disarray and pagetoid cells in the epidermis, 
nonedged papillae and cellular atypia at the 
junction, and atypical nests and bright nucle-
ated cells in the upper dermis. Benign lesions 
demonstrated regular dermal–epidermal archi-
tecture and the absence of pagetoid infiltration 
and atypical cells. Five melanomas with mildly 
atypical melanocytes and occasional pagetoid 
cells at histopathology were not diagnosed. Confocal microscopy may be most use-
ful for second-level examination of clinically and dermoscopically equivocal lesions. 
See page 2759
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CCBs & Eczema
In 102 older chronic eczema 
patients and 204 controls, Joly 
et al. compared drug use for 
more than 3 months within the 
year preceding an eruption. 
Chronic intake of calcium 
channel blockers (CCBs) was 
associated with eczema, with 
a matched odds ratio of 2.5. 
Two ancillary studies were 
then performed: after CCB 
withdrawal, eruptions healed 
in 83% of 74 patients with 
eczematous eruptions vs. 68% 
of 101 patients registered in the 
French drug-survey database. 
Long-term use of CCBs may 
be a risk factor for chronic or 
recurrent eczema in patients 
over age 60. See page 2766
Blood Vessels in Skin 
Inflammation
Podoplanin and lymphatic 
vascular endothelial 
hyaluronan receptor-1 (LYVE-
1) are lineage markers for 
lymphatic vessel endothelial 
cells (LECs), and IL-3 induces 
their de novo expression 
in cultured blood vessel 
endothelial cells (BECs). Gröger 
and colleagues compared 
inflamed skin samples and 
cytokine-stimulated organ-
cultured skin. A subset of 
blood capillaries within the 
papillary dermis expressed low 
amounts of podoplanin and 
LYVE-1 but high amounts of 
cytokine-inducible adhesion 
molecules; neighboring 
lymphatic capillaries expressed 
the reverse. When cytokine-
stimulated BECs and LECs 
were analyzed in cell cultures, 
the response patterns were 
reproducible, indicating that 
podoplanin and LYVE-1 should 
be considered activation 
markers for BEC. See page 2893
